United Effort Towards an HIV Cure

CRISPR for Cure is 1 of 10 Martin Delaney Collaboratories for HIV Cure in the country. We use cutting edge technology in basic and translational HIV cure research.

Learn about our program

Searching for a cure for the 38 million people living with HIV

It has been over 40 years since the first reported case of HIV and today we are closer to a cure than ever.

Our goal is to implement a genetic strategy using CRISPR gene editing platform for the permanent inactivation of HIV and enhancement of the immune system.

Collaborating for success

It takes a village to find an HIV cure. CRISPR for Cure is a highly collaborative and synergistic research program with academic, industry, government, and community partnerships.

Upcoming
Event

August 12, 2022: Webinar presented by Dr. Farzan on “Affinity maturation of human HIV-1 broadly neutralizing antibodies in wild-type mice”

Register now

What’s Happening

The Washington Post | 07/27/2022
Longtime HIV Patient is Effectively Cured After Stem Cell Transplant
Read more Read more link
The Temple News | 03/29/2022
Temple’s HIV Treatment Undergoes Clinical Trial
Read more Read more link
LKSOM at Temple University | 02/24/2022
First Clinical Trial CRISPR-Based HIV Therapy Founded on Breakthrough Research at LKSOM
Read more Read more link
Back to top